OrthoBiologics
Editat de Rachel M. Frank, Jorge Chahla, Garrett Jacksonen Limba Engleză Paperback – 21 aug 2024
In addition to covering current approaches and applications, the editors aim for this book to present “best practices” for those practicing and researching orthopaedic pathologies and orthobiologic treatments, including blood and cellular based therapies. The editors are world-renown experts in the field and this book fills a gap in the market.
- Presents the current state-of-the-art treatments for orthobiologics, including PRP, stem cell therapy, growth factors, scaffolds, and more
- Includes a comprehensive overview of orthobiologics, including definitions, terminology, processing characteristics, clinical outcomes, and more
- Presents current information on the ever-changing regulatory environment
- Provides real-time information on clinical and surgical utilization of orthobiologics
- Written for clinicians, researchers, and students, with content relevant to all those who participate in orthobiologic research and treatment, including orthopaedic surgeons, sports medicine specialists, rheumatologists, physiatrists, and any/all clinicians and researchers with an interest in orthobiologics and regenerative medicine.
Preț: 783.21 lei
Preț vechi: 1024.34 lei
-24% Nou
Puncte Express: 1175
Preț estimativ în valută:
149.94€ • 155.85$ • 124.31£
149.94€ • 155.85$ • 124.31£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Livrare express 01-07 ianuarie 25 pentru 98.63 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128229026
ISBN-10: 0128229020
Pagini: 280
Dimensiuni: 216 x 276 x 18 mm
Greutate: 0.77 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0128229020
Pagini: 280
Dimensiuni: 216 x 276 x 18 mm
Greutate: 0.77 kg
Editura: ELSEVIER SCIENCE
Cuprins
1. Autologous blood; platelet-rich plasma and platelet-poor plasma
2. Defining, measuring and optimizing platelet-rich plasma
3. Optimal use of platelet-rich plasma and plateletpoor plasma
4. Where orthobiologics started: what are mesenchymal stem cells?
5. Bone marrow-derived mesenchymal stromal cells
6. Defining, optimizing, and measuring bone marrow aspirate and bone marrow concentrate
7. Optimal clinical use of bone marrow aspirate and bone marrow aspirate concentrate
8. Adipose mesenchymal stromal cells
9. Defining, optimizing, measuring, and utilizing adipose, MFAT, etc.
10. Optimal clinical use of adipose mesenchymalstromal cells
11. Basic science and preclinical evidence for amniotic membrane2derived allografts in
12. Defining, optimizing, and measuring amniotic/ placental mesenchymal stem cells
13. Optimal clinical use of amniotic/placental mesenchymal stem cells
14. Synovial mesenchymal stem cells
15. Peripheral blood stem cells
16. Orthobiologics—growth factors and mediators
17. Orthobiologics in the procedure room—who, what, where, when, and how
18. Orthobiologics in the operating room—who, what, where, when, and how
19. The changing regulatory environment: regulations and restrictions
20. Bioscaffolds for osteochondral injuries of the knee
21. Orthobiologics on the horizon
22. Complications associated with orthobiologics
2. Defining, measuring and optimizing platelet-rich plasma
3. Optimal use of platelet-rich plasma and plateletpoor plasma
4. Where orthobiologics started: what are mesenchymal stem cells?
5. Bone marrow-derived mesenchymal stromal cells
6. Defining, optimizing, and measuring bone marrow aspirate and bone marrow concentrate
7. Optimal clinical use of bone marrow aspirate and bone marrow aspirate concentrate
8. Adipose mesenchymal stromal cells
9. Defining, optimizing, measuring, and utilizing adipose, MFAT, etc.
10. Optimal clinical use of adipose mesenchymalstromal cells
11. Basic science and preclinical evidence for amniotic membrane2derived allografts in
12. Defining, optimizing, and measuring amniotic/ placental mesenchymal stem cells
13. Optimal clinical use of amniotic/placental mesenchymal stem cells
14. Synovial mesenchymal stem cells
15. Peripheral blood stem cells
16. Orthobiologics—growth factors and mediators
17. Orthobiologics in the procedure room—who, what, where, when, and how
18. Orthobiologics in the operating room—who, what, where, when, and how
19. The changing regulatory environment: regulations and restrictions
20. Bioscaffolds for osteochondral injuries of the knee
21. Orthobiologics on the horizon
22. Complications associated with orthobiologics